Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HIV clade B DNA vaccine (PENNVAX-B) - Inovio

Next Previous
Search
Drug Profile

HIV clade B DNA vaccine (PENNVAX-B) - Inovio

Alternative Names: DNA vaccine for prevention of HIV clade B infection - Inovio; PENNVAX-B

Latest Information Update: 02 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of Pennsylvania
  • Developer Inovio Pharmaceuticals; University of Pennsylvania
  • Class AIDS vaccines; DNA vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 12 May 2014 Pharmacodynamics data from a phase I trial in HIV infections (in volunteers) released by Inovio Pharmaceuticals
  • 10 Jul 2013 Immunogenicity data from the HVTN 070 and HVTN 080 phase I trials in HIV-1 infections released by Inovio Pharmaceuticals
  • 08 Nov 2012 Inovio Pharmaceuticals completes a phase I trial in HIV-1 infections in USA (NCT01082692)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top